Curaleaf (CURA.C) closed their amended acquisition of the Cura Partners, owner of the Select brand, in an all-stock transaction. The company originally signed a definitive agreement on May 1,…
CURA.C
Curaleaf Holdings (CURA.C) got the Massachusetts Cannabis Control Commission’s nod for their three final and two provisional adult-use licenses today. The next step is to schedule their final inspections…
Curaleaf (CURA.C), the CSE-listed, U.S.-based multi-state operator (MSO), is now the target of several class-action lawsuits concerning the sale of products in violation of FDA regulations. Lawsuits by at…
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused…